Hematopathology
- 3rd Edition - September 4, 2024
- Authors: Elaine Sarkin Jaffe, Daniel A. Arber, Elias Campo, Leticia Quintanilla-Fend, Attilio Orazi, Lisa M. Rimsza, Steven H. Swerdlow
- Language: English
- Hardback ISBN:9 7 8 - 0 - 3 2 3 - 8 3 1 6 5 - 9
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 5 1 1 6 - 7
- eBook ISBN:9 7 8 - 0 - 3 2 3 - 8 3 1 6 6 - 6
**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Surgical Pathology**Covering the broad range of benign and malignant disorders that affect the h… Read more
Purchase options
**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Surgical Pathology**
Covering the broad range of benign and malignant disorders that affect the hematopoietic system, Hematopathology, 3rd Edition, remains your #1 source of authoritative information in this fast-changing field. Edited by Dr. Elaine Jaffe and a team of globally renowned, expert co-editors, it offers a wealth of up-to-date information in an easily accessible format, equipping you to deliver more accurate and actionable pathology reports. Comprehensive in scope, this highly illustrated, practical text is a must-have resource for residents and practicing pathologists alike.
Covering the broad range of benign and malignant disorders that affect the hematopoietic system, Hematopathology, 3rd Edition, remains your #1 source of authoritative information in this fast-changing field. Edited by Dr. Elaine Jaffe and a team of globally renowned, expert co-editors, it offers a wealth of up-to-date information in an easily accessible format, equipping you to deliver more accurate and actionable pathology reports. Comprehensive in scope, this highly illustrated, practical text is a must-have resource for residents and practicing pathologists alike.
- Helps you navigate the latest changes in the classification of hematolymphoid neoplasms, providing guidance for use of both the International Consensus Classification (ICC) and 5th edition of the WHO classification
- Incorporates the latest molecular/cytogenetic information, regarding newly recognized entities and the latest diagnostic criteria
- Provides you with today's most effective guidance in evaluating specimens from the lymph nodes, bone marrow, peripheral blood, and more, with authoritative information on the pathogenesis, clinical and pathologic diagnosis, and treatment for each
- Details the latest insights on the molecular biology of benign and malignant hematologic disorders
- Features more than 1,100 high-quality color images that mirror the findings you encounter in practice
- Uses an easy-to-navigate, templated format with standard headings in each chapter.
- Includes information on disease progression and prognosis, helping you better understand the clinical implications of diagnosis
- Shares the knowledge and expertise of new editors, Drs. Lisa Rimsza, Attilio Orazi, and Steven Swerdlow, providing expertise in molecular diagnostics, bone marrow and lymph node biopsies
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish up to 6 weeks following the publication date
Hematopathologists. General surgical pathologists in practice and in training
PART I Technical Aspects
1. Processing of the Lymph Node Biopsy Specimen
2. Fine-Needle Aspiration of Lymph Nodes
3. Immunohistochemistry for the Hematopathology Laboratory
4. Flow Cytometry
5. Molecular Pathology of Hematologic Neoplasms
6. Important Chromosomal Aberrations in Hematologic Neoplasms and Key Techniques to Diagnose Them
PART II Normal and Reactive Conditions of Hematopoietic Tissues
7. Normal Lymphoid Organs and Tissues
8. Reactive Lymphadenopathies
9. The Normal Bone Marrow
10. Evaluation of Anemia, Leukopenia, and Thrombocytopenia
11. Bone Marrow Findings in Inflammatory, Infectious, and Metabolic Disorders
PART III Lymphoid Neoplasms
12. Principles of Classification of Lymphoid Neoplasms
SECTION 1 • MATURE B-CELL NEOPLASMS
13. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Monoclonal B-Cell Lymphocytosis, and B-Cell Prolymphocytic Leukemia
14. Lymphoplasmacytic Lymphoma and Waldenström Macroglobulinemia
15. Hairy Cell Leukemia
16. Splenic Marginal Zone Lymphoma and Other Small B-Cell Neoplasms in the Spleen
17. Follicular Lymphoma
18. Extranodal Marginal Zone Lymphoma: MALT Lymphoma
19. Primary Cutaneous B-Cell Lymphomas
20. Nodal Marginal Zone Lymphoma
21. Mantle Cell Lymphoma
22. Aggressive B-Cell Lymphomas Including Diffuse Large B-Cell Lymphoma, Not Otherwise Specified and Other Nodal and Extranodal Large B-Cell Lymphomas
23. Burkitt Lymphoma, High-Grade B-Cell Lymphoma Not Otherwise Specified, High-Grade B-Cell Lymphoma With MYC and BCL2/BCL6 Rearrangements, Large B-Cell Lymphoma With 11q Aberration, and Provisional Entity High-Grade B-Cell Lymphoma With MYC and BCL6 Rearrangements
24. Plasmablastic Neoplasms Other Than Plasma Cell Myeloma
25. Plasma Cell Neoplasms
26. Nodular Lymphocyte-Predominant B-Cell Lymphoma
27. Classic Hodgkin Lymphoma
28. Virally Associated B-Cell Lymphoproliferative Disease
SECTION 2 • MATURE T-CELL AND NK-CELL NEOPLASMS
29. Epstein-Barr Virus–Associated T-Cell and Natural Killer–Cell Lymphoproliferative Disorders
30. T-Cell and NK-Cell Large Granular Lymphocyte Proliferations
31. T-Cell Prolymphocytic Leukemia
32. Adult T-Cell Leukemia/Lymphoma
33. Hepatosplenic T-Cell Lymphoma
34. Peripheral T-Cell Lymphoma, Not Otherwise Specified
35. Follicular Helper T-Cell Lymphoma
36. Anaplastic Large Cell Lymphoma, ALK Positive and ALK Negative
37. Enteropathy-Associated T-Cell Lymphoma and Other Primary Intestinal T-Cell Lymphomas
38. Mycosis Fungoides and Sézary Syndrome
39. Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorders
40. Primary Cutaneous T-Cell Lymphomas: Rare Subtypes
SECTION 3 • PRECURSOR B- AND T-CELL NEOPLASMS
41. Precursor B-Cell and T-Cell Neoplasms
42. Acute Leukemias of Ambiguous Lineage
PART IV Myeloid, Histiocytic, and Related Proliferations
43. Principles of Classification of Myeloid Neoplasms
44. The Myelodysplastic Syndromes
45. Myeloid and Hematologic Neoplasms With Germline Predisposition
46. Acute Myeloid Leukemia
47. Myeloproliferative Neoplasms
48. Myelodysplastic/Myeloproliferative Neoplasms and Premalignant Conditions
49. Mastocytosis
50. Eosinophilia, Chronic Eosinophilic Leukemia, Not Otherwise Specified, and Myeloid/Lymphoid Neoplasms With Eosinophilia and Tyrosine Kinase Gene Fusions
51. Blastic Plasmacytoid Dendritic Cell Neoplasm
52. Histiocytic and Dendritic Cell Proliferations—Systemic and Neoplastic
PART V Immunodeficiency Disorders
53. The Pathology of Primary Immunodeficiencies
54. Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders
PART VI Site-Specific Issues in the Diagnosis of Lymphoma and Leukemia
55. Bone Marrow Evaluation for Lymphoma
56. Evaluation of the Bone Marrow After Therapy
57. Non-hematopoietic Neoplasms and Other Lesions of the Bone Marrow and Lymph Nodes
58. Spleen: Normal Architecture and Neoplastic and Non-neoplastic Lesions
59. Diagnosis of Lymphoma in Extranodal Sites Other Than Skin
APPENDIX A: THE INTERNATIONAL CONSENSUS CLASSIFICATION OF MYELOID, LYMPHOID, AND HISTIOCYTIC NEOPLASMS
- Edition: 3
- Published: September 4, 2024
- Language: English
EJ
Elaine Sarkin Jaffe
Dr. Elaine Jaffe is regarded by her peers as one of the most pre-eminent hematopathologists of her generation. She is most widely known for her work regarding the pathophysiology and prognosis of malignant lymphomas, as well as her unparalleled work to understand how they respond to treatment. Dr. Jaffe led the effort to develop the World Health Organization classification of tumors of the hematopoietic and lymphoid tissues published in 2001, a classification that rapidly became the international standard.
Affiliations and expertise
Chief, Hematopathology Section, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health; Clinical Professor of Pathology, George Washington University School of Medicine; Series Editor, World Health Organization Classification of Tumours 4th Edition, International Agency for Research on Cancer, Bethesda, Maryland, USADA
Daniel A. Arber
Dr. Daniel Arber is an internationally recognized expert in the diagnosis and classification of hematopoietic tumors, including malignant lymphoma, acute and chronic leukemia, myeloproliferative disorders, myelodysplastic syndrome and tumors of the spleen.
Affiliations and expertise
Professor and Chair of Pathology, University of Chicago School of Medicine, USAEC
Elias Campo
the clinical director of the Biomedical Diagnostic Centre of Hospital Clinic and a full Professor of Anatomical Pathology at the University of Barcelona, where he also teaches in the Department of Anatomical Pathology, Pharmacy and Microbiology. He is the Spanish coordinator of the International Cancer Genome Consortium.
Affiliations and expertise
Chief, Hematopathology Unit, Professor of Anatomic Pathology, Clinical Director, Center for Biomedical Diagnosis, Hospital Clinic, University of Barcelona, Barcelona, SpainLQ
Leticia Quintanilla-Fend
Professor Dr. Leticia Quintanilla de Fend, head of the Core Facility and Senior Physician at the Institute of Pathology has extensive experience in the interpretation of mouse models. From 2000 until 2008 she was a director of the mouse pathology at the Institute of Pathology of the Helmholtz Center Munich and the Pathology Screen of the German Mouse Clinic (GMC) and established various special procedures for the analysis of mouse models. Professor Quintanilla de Fend is involved in the establishment of standards in the pathology of mouse models within EU networks.
Affiliations and expertise
Associate Professor, Institute of Pathology, Eberhard-Karls-University; Senior Staff, Institute of Pathology, University Hospital and Comprehensive Cancer Center, Tübingen, GermanyAO
Attilio Orazi
Dr. Attilio Orazi is an internationally renowned academic hematopathologist whose diagnostic expertise spans all areas of hematopathology. However, he is best known for his expertise and scholarly accomplishments as a bone marrow pathologist. He is a member of the Scientific Committee of the European Bone Marrow Working Group, has directed courses concerning the assessment of bone marrow disorders and splenic pathology at the United States and Canadian Academy of Pathology and was the co-organizer of the 2007 Workshop of the Society of Hematopathology.
Affiliations and expertise
Chair, Department of Pathology, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USALR
Lisa M. Rimsza
Affiliations and expertise
Department of Pathology, Mayo Clinic, USASS
Steven H. Swerdlow
Affiliations and expertise
Professor of Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA